Boron neutron capture therapy for glioblastoma: Is it worth pursuing?

Technology in Cancer Research and Treatment

Volumn 7, Issue 1, 2008, Pages 83-88

  Linz, Ute ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

BNCT; Brain tumors; Glioblastoma; Radiotherapy

Indexed keywords

4 BORONOPHENYLALANINE; BORON; EPIDERMAL GROWTH FACTOR RECEPTOR; SODIUM MERCAPTODODECABORATE; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CALCULATION; CELL DEATH; CONCENTRATION RESPONSE; CYTOLOGY; ENERGY TRANSFER; FISSION NEUTRON; GLIOBLASTOMA; MEMBRANE TRANSPORT; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NONHUMAN; REVIEW; TUMOR CELL;

EID: 39049086861     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460800700110     Document Type: Review

References (36)

1. van Rij, C. M., Wilhelm, A. J., Sauerwein, W. A. G., van Loenen, A. C. Boron neutron capture therapy for glioblastoma multiforme. Pharm World Sci 27, 92-95 (2005).
2. Diaz, A. Z. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view. J Neuro-Oncol 62, 101-109 (2003).
3. Skarsgard, L. D. Radiobiology with heavy charged particles: a historic review. Phys Med 14 (suppl 1), 1-19 (1998).
4. Farr, L. E., Sweet, W. H., Robertson, J. S., et al. Neutron capture with boron in the treatment of glioblastoma multiforme. Am J Roentenol Rad Ther Nucl Med 71, 279-291 (1954).
5. Barth, R. F., Coderre, J. A., Vicente, M. G., Blue, T. E. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11, 3987-4002 (2005).
6. Gupta, N., Gahbauer, R. A., Blue, T. E., Albertson, B. Common challenges and problems in clinical trials of boron neutron capture therapy of brain tumors. J Neuro-Oncol 62, 197-210 (2003).
7. Smith, D. R., Chandra, S., Barth, R. F., et al. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Cancer Res 61, 8179-8187 (2001).
8. Papaspyrou, M., Feinendegen, L. E., Müller-Gärtner, H. W. Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells. Cancer Res 54, 6311-6314 (1994).
9. Tolpin, E. I., Wellum, G. R., Dohan, F. C. Jr, et al. Boron neutron capture therapy of cerebral gliomas-II. Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomas. Oncology 32, 223-246 (1975).
10. Coderre, J. A., Chanana, A. D., Joel, D. D., et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Rad Res 149, 163-170 (1998).
11. Dahlström, M., Capala, J., Lindström, P., et al. Accumulation of boron in human malignant glioma cells in vitro is cell type dependent. J Neuro-Oncol 68, 199-205 (2004).
12. Barth, R. F., Joensuu, H. Boron neutron capture therapy for the treatment of glioblastomas and extracranial tumours: as effective, more effective or less effective than photon irradiation? Radiother Oncol 82, 119-122 (2007).
13. Barth, R. F., Yang, W., Coderre, J. A. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation. J Neuro-Oncol 62, 61-74 (2003).
14. Hawthorne, M. F., Lee, M. W. A critical assessment of boron target compounds for boron neutron capture therapy. J Neuro-Oncol 62, 33-45 (2003).
15. Barth, R. F., Yang, W., Adams, D. M., et al. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Cancer Res 62, 3159-3166 (2002).
16. Gabel, D., Foster, S., Fairchild, R. G. The Monte Carlo simulation of the biological effect of the 10B(n, alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Rad Res 111, 14-25 (1987).
17. van Vliet-Vroegindeweij, C., Wheeler, F., Stecher-Rasmussen, F., et al. Microdosimetry model for boron neutron capture therapy: I. Determination of microscopic quantities of heavy particles on a cellular scale. Rad Res 155, 490-497 (2001).
18. Buchegger, F., Perillo-Adamer, F., Dupertuis, Y. M., Delaloye, A. B. Auger radiation targeted into DNA: a therapy perspective. Europ J Nucl Med Mol Imaging 33, 1352-1363 (2006).
19. Hatanaka, H., Nakagawa, Y. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int J Rad Oncol Biol Phys 30, 1061-1066 (1994).
20. Nakagawa, Y., Hatanaka, H. Boron neutron capture therapy. Clinical brain tumor studies. J Neuro-Oncol 33, 105-115 (1997).
21. Hatanaka, H. A revised boron-neutron capture therapy for malignant brain tumors. II. Interim clinical result with the patients excluding previous treatments. J Neurol 209, 81-94 (1975).
22. Durrant, K. R., Hopewell, J. W. Fractionation and other clinical considerations in boron neutron capture therapy. Strahlenther Onkol 165, 231-233 (1989).
23. Gabel, D., Sauerwein, W. Clinical implementation of boron neutron capture therapy in Europe. In Hadrontherapy in Oncology, pp. 509-517. Eds., Amaldi, U., Larsson, B. Amsterdam, Elsevier Science (1994).
24. Laramore, G. E., Spence, A. M. Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: a cautionary note. Int J Rad Oncol Biol Phys 36, 241-246 (1996).
25. Nakagawa, Y., Pooh, K., Kobayashi, T., et al. Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J Neuro-Oncol 62, 87-99 (2003).
26. Joensuu, H., Kankaanranta, L., Seppala, T., et al. Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine. J Neuro-Oncol 62, 123-134 (2003).
27. Capala, J., Stenstam, B. H., Skold, K., et al. Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neuro-Oncol 62, 135-144 (2003).
28. Florell, R. C., Macdonald, D. R., Irish, W. D., et al. Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76, 179-183 (1992).
29. Loeffler, J. S., Alexander, E., Wen, P. Y., et al. Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 82, 1918-1921 (1990).
30. Videtic, G. M., Gaspar, L. E., Zamorano, L., et al. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis. Int J Rad Oncol Biol Phys 51, 963-968 (2001).
31. Moss, R., McGarry, D. Boron neutron capture therapy. Available at http://ie.jrc.cec.eu.int/publications/info_sheets_docs/Info%20Sheet%20BNCT.pdf. Accessed January 29, 2007.
32. Henriksson, R., Capala, J., H-Stenstam, B., et al. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase 2 study evaluating a prolonged high dose of boronophenylalanine (BPA). Radiother Oncol 79, 150-157 (2006) (RETRACTED Sep. 2006).
33. Rassow, J., Sauerwein, W., Wittig, A., et al. Advantage and limitations of weighting factors and weighted dose quantities and their units in boron neutron capture therapy. Med Phys 31, 1128-1134 (2004).
34. Ono K, Ueda S, Oda Y, et al. Boron neutron capture therapy for malignant glioma at Kyoto University Reactor [abstract]. In: Seventh International Symposium on Neutron Capture Therapy for Cancer. Zurich, 4-7 Sept. 1996, pp. 161. Eds., Larsson, B., Crawford, J. (1996).
35. Yamamoto, T., Matsumura, A., Nakai, K., et al. Current clinical results of the Tsukuba BNCT trial. Applied Radiat Isotopes 61, 1089-1093 (2004).
36. Vos, M. J., Turowski, B., Zanella, F. E., et al. Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961. Int J Rad Oncol Biol Phys 61, 392-399 (2005).